• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/24

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

24 Cards in this Set

  • Front
  • Back
22. Stage 1 COPD (out of Stages 0-5): Classification?
a. Mild COPD
23. Stage 1 COPD (out of Stages 0-5): Findings?
a. FEV1:FVC <0.7
b. FEV1≥80% of predicted
c. With or without symptoms
24. Stage 1 COPD (out of Stages 0-5): Treatment?
a. Short acting bronchodilators (albuterol and ipratropium)
25. Stage 2 COPD (out of Stages 0-5): Classification?
a. Moderate COPD
26. Stage 2 COPD (out of Stages 0-5): Findings?
a. FEV1:FVC <0.7
b. FEV1 50-80% of predicted
c. With or without symptoms
27. Stage 2 COPD (out of Stages 0-5): Treatment?
a. Long-acting bronchodilators: Salmeterol and Ipratropium (inhaled anticholinergic)
28. Stage 3 COPD (out of Stages 0-5): Classification?
a. Severe COPD
29. Stage 3 COPD (out of Stages 0-5): Findings?
a. FEV1:FVC <0.7
b. FEV1 30-50% of predicted
c. With or without symptoms
30. Stage 3 COPD (out of Stages 0-5): Treatment?
a. Inhaled steroids
31. Stage 4 COPD (out of Stages 0-5): Classification?
a. Very severe COPD
32. Stage 4 COPD (out of Stages 0-5): Findings?
a. FEV1:FVC <0.7
i. FEV1 <30% of predicted
ii. Or
iii. FEV1 <50% with hypoxemia (PAO2 ≤55 or SaO2 ≤88% at rest) or PaO2 ≤60 +polycythemia, pulm HTN, or peripheral oedema).
33. Stage 4 COPD (out of Stages 0-5): Treatment?
a. Consider oxygen therapy + inhaled steroids
34. Note: although smoking cessation does not result in significant improvement in pulmonary function, smoking cessation does reduce the rate of further deterioration to that of a non-smoker.
a. Cessation also reduces the risks of other comorbidities, including cardiovascular diseases and cancers
35. We should all patients with COPD receive?
a. Pneumococcal and annual influenza vaccination
b. Influenza vaccination reduces the frequency and complication of exacerbations
c. Regular exercise and efforts to maintain normal body weight should be encouraged.
36. What is the use of inhaled steroids (fluticasone, triamcinolone, mometasone) in COPD?
a. They do not affect the rate of decline of lung function in COPD but do reduce the frequency of exacerbations.
b. For this reason, inhaled steroids are recommended for stages 3 and 4 COPD with frequent exacerbation!!!!
37. Note: long-term treatment with oral steroids is not recommended, as there is no evidence of benefit, but there can be multiple complications (myopathy, osteoporosis, glucose intolerance, etc).
37. Note: long-term treatment with oral steroids is not recommended, as there is no evidence of benefit, but there can be multiple complications (myopathy, osteoporosis, glucose intolerance, etc).
38. What is the only therapy that has been shown to decrease mortality in COPD?
a. Oxygen therapy
b. It must be worn for at least 15 hours per day!!!!
39. Goal for oxygen therapy during an acute COPD exacerbation?
a. Keep SaO2 > 90% or PaO2 at about 60 mm Hg.
40. What shortens the course of a COPD exacerbation and may reduce the risk of relapse?
a. Systemic steroids
41. How much oral steroids be given for COPD exacerbation
a. 40 mg prednisone (or equivalent) for 10 to 14 days is recommended!!!
42. When should COPD exacerbations be treated with abx?
a. When there is an increased amount of sputum or with purulent sputum.
43. Most commonly implicated organisms in COPD exacerbation (3)?
1. Pneumococcus
2. Haemophilus influenza
3. Moraxella catarrhalis
44. Aetiology of severe COPD exacerbation?
a. Gram-negative bacteria (Klebsiella, Pseudomonas) also play a role, so abx coverage needs to be broader.
45. complete
45. complete